XILIO THERAPEUTICS

xilio-therapeutics-logo

Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The companyโ€™s tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across can... cer types means that all patients could benefit from these potentially curative medicines. These tumor-selective therapies are designed to overcome the significant toxicities associated with validated IO therapies, such as IL-2 and aCTLA4, which have historically limited the number of patients that can be treated and prevented patients from completing full courses of treatment Xilio Therapeutics proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. The company applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. Xilio Therapeutics was founded in 2016 and is headquartered in Waltham, Massachusetts, United States.

#People #Financial #Event #Website #More

XILIO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2016-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.akriveiatx.com

Total Employee:
11+

Status:
Active

Contact:
(609)560-0927

Email Addresses:
[email protected]

Total Funding:
233 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager Content Delivery Network Font Awesome Apache Global Site Tag



Current Advisors List

ben-auspitz_image

Ben Auspitz Board of Directors @ Xilio Therapeutics
Board_member
2016-10-01

nancy-hong_image

Nancy Hong Board of Director @ Xilio Therapeutics
Board_member

jayson-punwani_image

Jayson Punwani Board of Director @ Xilio Therapeutics
Board_member

thomas-r-beck_image

Thomas R. Beck Board of Directors @ Xilio Therapeutics
Board_member
2016-10-01

peter-dudek_image

Peter Dudek Board of Director @ Xilio Therapeutics
Board_member

michael-ross_image

Michael Ross Board of Director @ Xilio Therapeutics
Board_member

andrew-hack_image

Andrew Hack Board Member @ Xilio Therapeutics
Board_member
2021-02-24

not_available_image

Dave Gardner Board Member @ Xilio Therapeutics
Board_member
2021-02-24

Current Employees Featured

rene-russo_image

Rene Russo
Rene Russo CEO @ Xilio Therapeutics
CEO
2019-05-01

simon-tomlinson_image

Simon Tomlinson
Simon Tomlinson CEO @ Xilio Therapeutics
CEO

uli-rodeck_image

Uli Rodeck
Uli Rodeck Co-founder @ Xilio Therapeutics
Co-founder

timothy-p-clackson_image

Timothy P. Clackson
Timothy P. Clackson President, and EVP R&D @ Xilio Therapeutics
President, and EVP R&D
2018-05-01

joseph-farmer_image

Joseph Farmer
Joseph Farmer COO @ Xilio Therapeutics
COO
2019-05-01

c-glenn-begley_image

C. Glenn Begley
C. Glenn Begley CSO @ Xilio Therapeutics
CSO

john-c-williams_image

John C. Williams
John C. Williams Co-founder @ Xilio Therapeutics
Co-founder

not_available_image

Timothy D. Hunt
Timothy D. Hunt Chief Culture and Corporate Affairs Officer @ Xilio Therapeutics
Chief Culture and Corporate Affairs Officer
2021-10-01

martin-huber_image

Martin Huber
Martin Huber Chief Medical Officer @ Xilio Therapeutics
Chief Medical Officer
2020-04-01

ronan-ohagan_image

Ronan O&s;Hagan
Ronan O'Hagan SVP, Research and Translational Sciences @ Xilio Therapeutics
SVP, Research and Translational Sciences
2018-06-01

Founder


john-c-williams_image

John C. Williams

uli-rodeck_image

Uli Rodeck

Stock Details


Company's stock symbol is NASDAQ:XLO

Investors List

rivervest_image

RiverVest

RiverVest investment in Series C - Xilio Therapeutics

deerfield_image

Deerfield

Deerfield investment in Series C - Xilio Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series C - Xilio Therapeutics

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series C - Xilio Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Xilio Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series C - Xilio Therapeutics

mrl-venture-fund_image

MRL Ventures Fund

MRL Ventures Fund investment in Series C - Xilio Therapeutics

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series C - Xilio Therapeutics

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Series C - Xilio Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Xilio Therapeutics

Official Site Inspections

http://www.akriveiatx.com

  • Host name: 172.65.190.172
  • IP address: 172.65.190.172
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Xilio Therapeutics" on Search Engine